Enteric fever in 19 children cases with positive hemocultures;Çocuklarda kültür pozitif enterik ateş

Cocuk Sagligi ve Hastaliklari Dergisi

Volumn 49, Issue 1, 2006, Pages 19-23

  Katar, Selahattin ^a,c   Onur, Hakan ^b,c   Yaramiş, Ahmet ^a,c   Özbek, M Nuri ^b,c   Ecer, Sultan ^a,c  

^a DICLE UNIVERSITY   (Turkey)

^b Diyarbakir Çocuk Hastanesi ^*  (Turkey)

^c DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Child; Clinical findings; Culture positive; Enteric fever

Indexed keywords

AMINOTRANSFERASE; C REACTIVE PROTEIN; CEFIXIME; CEFOPERAZONE; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE;

ABDOMINAL TENDERNESS; ANEMIA; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HEPATOMEGALY; HUMAN; LEUKOPENIA; MALE; RETROSPECTIVE STUDY; SALMONELLA TYPHI; SCHOOL CHILD; THROMBOCYTOPENIA; TURKEY (REPUBLIC); TYPHOID FEVER;

EID: 33645310199     PISSN: 00100161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kapoor JP, Mohan M, Talwar V, et al. Typhoid fever in young children. Indian Pediatr 1985; 22: 811-813.
2. Arora RK, Gupta A, Joshi NM, et al. Multidrug resistant typhoid fever: study of an autbreak in Calcutta. Indian Pediatr 1992; 29: 61-66.
3. Choo KE, Razif A, Arrifin WA, Sepiah M, Gururaj A. Typhoid fever in hospitalized children in Kelentan, Malaysia. Ann Trop Pediatr 1988; 8: 207-212.
4. Johnson AO, Aderele WI. Enteric fever in childhood. J Trop Med Hyg 1981; 84: 29-35.
5. Ha V, Wain J, Vo TH, et al. Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children. Antimicrob. Agents Chemother 1996; 40: 958-961.
6. Akan Ö, Kanra G, Seçmeer G, Ceylan M, Ecevit Z, Berkman E. Antibiotic susceptibilities of Salmonella serogroups isolated from Turkish children. Turk J Pediatr 1997; 39: 7-11.
7. Ünal S, Hayran M, Tuncer S, et al. Treatment of enteric fever with pefloxacin for 7 days versus 5 days: a randomized clinical trial. Antimicrob Agents Chemother 1996; 40: 2898-2900.
8. Bhutta ZA, Mansoorali N, Hussain R. Plasma cytokines in paediatric typhoidal salmonellosis: correlation with clinical course and outcome. J Infect 1997; 35: 253-256.
9. Acharya G, Butler T, Ho M, et al. Treatment of typhoid fever: randomized trial of a 3-day course of ceftriaxone versus a 14-day course of chloramphenicol. Am J Trop Med Hyg 1995; 52: 162-165.
10. Ministry of Health (Turkey), Hacettepe Universty Institute of Population Studies, Macro International Inc. 1994. Turkish Demographic and Health Survey, Ankara, Turkey, 1993: 87-106.
11. Yaramis A, Yildirim İ, Katar S, et al. Clinical and laboratory presentation of typhoid fever. Pediatr Int 2001; 16: 227-231.
12. Tatli MM, Aktaş G, Kösecik M, Yilmaz A. Treatment of typhoid fever in children with a flexible-duration of ceftriaxone, compared with 14-day treatment with chloramphenicol. Int J Antimicrob Agents 2003; 4: 350-353.
13. Seçmeer G, Kanra G, Cemeroǧlu AP, Özen H, Ceyhan M, Ecevit Z. Salmonella typhi infections: a 10-year retrospective study. Turk J Pediatr 1995; 37: 339-341.
14. Oh HM, Chew SK, Manteiro EH. Multi-drug resistant typhoid fever in Singapore. Sing Med J 1994; 35: 559-601.
15. Butler T, Islasm A, Kabir I, Jones PK. Patterns of morbidity and mortality in typhoid fever dependent on age and gender: review of 552 hospitalized patients with diarrhea. Rev Infect Dis 1991; 13: 85-90.
16. Adesunkanmi AR, Ajao OG. The prognostic factors in typhoid ileal perforation: a prospective study of 50 patients. JR Coll Surg Edinb, 1997; 42: 395-399.
17. Akgun Y, Bac B, Boylu S, Aban N, Tacyildiz İ. Typhoid enteric perforation. Br J Surg 1995; 82: 1512-1515.
18. th ed). London: WB Saunders, 1996: 849-64.
19. Thisyakorn U, Mansuwan P, Taylor DN. Typhoid and paratyphoid fever in 192 hospitalized children in Thailand. Am J Child 1987; 141: 862-865.
20. Miller SI, Pegues DA. Salmonella species, including Salmonella typhi. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases. New York: Churchil Livingston, 2000: 2344-2363.
21. Bhutta ZA, Naqvi SH, Razzaq RA, Farooqui BD, Multidrug-resistant typhoid in children presentation and clinical features. Rev Infect Dis 1991; 13: 832-836.
22. Acharya G, Crevisier C, Butler T, et al. Pharmacokinetics of ceftriaxone in patients with typhoid fever. Antimicrob Agents Chemother 1994; 38: 24185-24188.
23. Rathore MH, Bux D, Hasan M. Multidrug-resistant Salmonella typhi in Pakistani children clinical features and treatment. South Med J 1996; 89: 235-237.
24. Memon IA, Billoo AG, Memon HI. Cefixime: an oral option for the treatment of multidrug-resistant enteric fever in children. South Med J 1997; 90: 1204-1207.
25. Ti TY, Monteiro EH, Lam S, Lee HS. Ceftriaxone therapy in bacteremic typhoid fever. Antimicrob Agents Chemother 1985; 28: 540-543.
26. Wilke A, Atalay G, Erdem B. The susceptibility of Salmonella spp to various antibiotics. Mikrobiol Bul 1988; 22: 17-24.
27. Olarte J, Galindo E. Salmonella typhi resistant to chloramphenicol, ampicillin and other antimicrobial agents: strains isolated during an extensive typhoid fever epidemic in Mexico. Antimicrob Agents Chemother 1973; 4: 597-601.
28. Rasaily R, Dutta P, Saha MR, Mitra U, Lahiri M, Pal SC. Multi-drug resistant typhoid fever in hospitalised children. Clinical, bacteriological and epidemiological profiles. Eur J Epidemol 1994; 10: 41-46.
29. Cao XT, Kneen R, Nguyen TA, Truong TL, White NJ, Parry CM. A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. The Dong Nai Pediatric Center Typhoid Study Group. Pediatr Infect Dis J 1999; 18: 245-248.